Glipizide XL — Class III drug recall D-1059-2014
Terminated recall by Greenstone Llc, reported 2014-02-12, distributed nationwide. Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 1
| Recall number | D-1059-2014 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Greenstone Llc, Peapack, NJ, United States |
| Recall initiated | 2013-11-04 |
| Classified | 2014-02-03 |
| Reported by FDA | 2014-02-12 |
| Terminated | 2015-06-24 |
| Distributed | Nationwide (US) |
| Quantity | 22,529 bottles |
| Reason classes | specification failure |
| NDC | 59762-5032-02 |
| Lot numbers | V112000 |
| Expiration dates | 2016-06-20 |
Product
Glipizide XL (glipizide) extended release tablets, 5 mg , 500 count bottles, Rx only, Distributed by: Greenstone Ltd., Peapack, NJ --- NDC 59762-5032-2
Reason for recall
Failed Dissolution Specification; the bulk lot yielded an out of specification result at the 8 hr timepoint, 18 month interval
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1059-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.